Ali M Harandi Selected Research

Viral Vaccines

1/2016

Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali M Harandi Research Topics

Disease

23	Infections 12/2023 - 04/2001
9	Herpes Genitalis (Genital Herpes) 01/2016 - 01/2003
5	Human Influenza (Influenza) 01/2023 - 09/2012
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2016 - 12/2005
4	Communicable Diseases (Infectious Diseases) 05/2023 - 04/2003
3	Vesicular Stomatitis 12/2023 - 12/2017
3	COVID-19 01/2023 - 01/2021
2	Whooping Cough (Pertussis) 12/2023 - 09/2015
2	Virus Diseases (Viral Diseases) 05/2023 - 05/2009
2	Arthritis (Polyarthritis) 01/2023 - 01/2023
2	Viremia 01/2023 - 12/2017
2	Cutaneous Leishmaniasis 03/2020 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 01/2016
2	Tuberculosis (Tuberculoses) 09/2015 - 03/2010
2	Inflammation (Inflammations) 12/2009 - 04/2001
2	Reinfection 01/2003 - 04/2001
1	Ebola Hemorrhagic Fever 12/2023
1	Myalgia 01/2023
1	Fatigue 01/2023
1	Fever (Fevers) 01/2023
1	Headache (Headaches) 01/2023
1	Nausea 01/2023
1	Arthralgia (Joint Pain) 01/2023
1	Chills 01/2023
1	Syphilis 01/2021
1	Gonorrhea 01/2021
1	Cytopenia 12/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2010
1	Malaria 03/2010
1	Meningococcal Meningitis 02/2010
1	Body Weight (Weight, Body) 10/2009
1	Pneumonia (Pneumonitis) 10/2009
1	Cholera 04/2003

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 12/2023 - 04/2003
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2006
7	AntibodiesIBA 12/2023 - 04/2001
6	Glycoproteins (Glycoprotein)IBA 12/2023 - 06/2008
6	OligodeoxyribonucleotidesIBA 10/2009 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 12/2005 - 04/2003
4	AntigensIBA 11/2022 - 04/2003
4	CPG-oligonucleotideIBA 12/2009 - 01/2003
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
3	Cholera ToxinIBA 10/2009 - 04/2003
2	Immunoglobulin A (IgA)IBA 12/2023 - 01/2016
2	Hemagglutinins (Hemagglutinin)IBA 01/2023 - 09/2012
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
2	glycoprotein D-herpes simplex virus type 2IBA 06/2012 - 12/2005
2	Myeloid Differentiation Factor 88IBA 06/2008 - 06/2008
1	Ebola VaccinesIBA 12/2023
1	EpitopesIBA 01/2023
1	Protein SIBA 01/2023
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2023
1	glucopyranosyl lipid-AIBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	NucleoproteinsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CytokinesIBA 01/2018
1	Adenosine DeaminaseIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2016
1	Viral VaccinesIBA 01/2016
1	Poly IIBA 01/2016
1	poly(I).poly(c12,U) (ampligen)IBA 01/2016
1	Poly I-CIBA 01/2016
1	Vaccine AdjuvantsIBA 03/2010
1	OvalbuminIBA 10/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2009
1	alpha-galactosylceramideIBA 05/2009
1	CXC ChemokinesIBA 06/2006
1	A-Form DNA (A-DNA)IBA 12/2005
1	DNA VaccinesIBA 12/2005
1	Bacterial DNAIBA 07/2004
1	Thymidine KinaseIBA 04/2001

Therapy/Procedure

3	Immunotherapy 03/2005 - 04/2003
1	Intranasal Administration 09/2012
1	Intravaginal Administration 06/2008
1	Mucosal Administration 06/2006